Apellis Pharmaceuticals logo
Apellis Pharmaceuticals APLS
report update icon

Quarterly report 2026-Q1
added 11-14-2026

Apellis Pharmaceuticals Operating Cash Flow | APLS

Annual Operating Cash Flow Apellis Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
45.3 M -87.9 M -595 M -514 M -563 M -160 M -211 M -131 M -46.6 M -26 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
45.3 M -595 M -229 M

Quarterly Operating Cash Flow Apellis Pharmaceuticals

2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-61 M -14.2 M 108 M 4.44 M -53.4 M - 34.1 M -8.34 M -133 M -97.9 M -169 M -150 M -178 M -141 M -154 M -107 M -112 M -112 M -169 M -129 M -153 M 142 M -99.8 M -94.3 M -108 M -82.1 M -53.6 M -39.9 M -35.6 M -44.5 M -33.1 M -30.7 M -22.9 M -15.5 M -31.1 M -19.9 M - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
142 M -178 M -67.5 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer Operating Cash Flow Price % 24h Market Cap Country
Brickell Biotech Brickell Biotech
BBI
-4.34 M - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-84.3 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
-22.7 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
-88.6 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-24.7 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
-186 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
-83.3 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
-186 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-8.87 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-22 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
-257 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-630 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-1.83 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-6.32 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
-49.5 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
-43.9 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
-31.1 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
-48.6 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
-69.6 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
-47.2 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
-1.21 B - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-269 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-17.8 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-24.5 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-230 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-122 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
-80.7 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-4.37 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
1.93 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
-63.7 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-230 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-13.7 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-177 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-26.8 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
-16.7 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-8.99 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
-45 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-32.1 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
41 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-108 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-260 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
-20.5 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
-21.1 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
-46 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
-51.5 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
-41.7 M - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
-132 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
-65.1 M - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-53.7 M - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-378 M $ 84.95 0.13 % $ 7.99 B usaUSA